Patent · US Active

Solid state forms of macrocyclic kinase inhibitors

US9120815B2 · kind B2 · utility

4Cited by

32References

16Claims

0Family size

Assignee

Tragara Pharmaceuticals, Inc. · US

Inventors

Robert K. Mansfield · San Marcos, US
Tracy Lawhon · San Diego, US
Brian William Dymock · Singapore, SG

Key dates

Filing date	Feb 4, 2011
Grant date	Sep 1, 2015
Priority date	—
Expiry date	Feb 4, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Provided herein are salt forms of macrocyclic protein kinase inhibitors, pharmaceutical compositions containing the same, methods of making and using these compounds and compositions to treat proliferative disease mediated by kinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.